Szerző: " Szalay Balázs"

Vissza
Export [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Találatok száma: 13.

Burcsár Szilárd; Toldi Gergely; Kovács László; Szalay Balázs; Vásárhelyi Barna; Balog Attila: Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity.
BIOMARKERS, 26 (5). pp. 443-449. ISSN 1354-750X (2021)

Iliás Ákos; Szántó Kata; Gönczi Lóránt; Kürti Zsuzsanna; Golovics Petra Anna; Farkas Klaudia; Szepes Zoltán; Szalay Balázs; Vincze Áron; Molnár Tamás; Lakatos Péter László: Outcomes of Patients With Inflammatory Bowel Diseases Switched from Maintenance Therapy with a Biosimilar to Remicade.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 17 (12). pp. 2506-2513. ISSN 1542-3565 (2019)

Dulic Sonja; Vásárhelyi Zsófia; Bajnok Anna; Szalay Balázs; Toldi Gergely; Kovács László; Balog Attila: The impact of anti-TNF therapy on CD4+ and CD8+ cell subsets in ankylosing spondylitis.
PATHOBIOLOGY, 85 (3). pp. 201-210. ISSN 1015-2008 (2018)

Gönczi Lóránt; Kürti Zsuzsanna; Rutka Mariann; Végh Zsuzsanna; Farkas Klaudia; Lovász Barbara Dorottya; Golovics Petra Anna; Gecse Krisztina Barbara; Szalay Balázs; Molnár Tamás; Lakatos Péter László: Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases.
BMC GASTROENTEROLOGY, 17 (1). Azonosító: 97.-Terjedelem: 7 p.. ISSN 1471-230X (2017)

Dulic Sonja; Vásárhelyi Zsófia; Sava Florentina; Berta László Gergely; Szalay Balázs; Toldi Gergely; Kovács László; Balog Attila: T-cell subsets in rheumatoid arthritis patients on long-term anti-TNF or IL-6 receptor blocker therapy.
MEDIATORS OF INFLAMMATION, 2017. Azonosító: 6894374-Terjedelem: 19 p.. ISSN 0962-9351 (2017)

Gecse Krisztina Barbara; Lovász Barbara Dorottya; Farkas Klaudia; Banai János; Bene László; Gasztonyi Beáta; Golovics Petra Anna; Csontos Ágnes Anna; Juhász Márk; Nagy Ferenc; Papp Mária; Szepes Zoltán; Vincze Áron; Szalay Balázs; Molnár Tamás; Lakatos Péter László: Efficacy and safety of the biosimilar infliximab CT-P13 treatment in inflammatory bowel diseases: a prospective; multicentre; nationwide cohort.
JOURNAL OF CROHNS & COLITIS, 10 (2). pp. 133-140. ISSN 1873-9946 (2016)

Legány Nóra; Toldi Gergely; Distler Jörg H.W.; Beyer Christian; Szalay Balázs; Kovács László; Vásárhelyi Barna; Balog Attila: Increased plasma soluble urokinase plasminogen activator receptor levels in systemic sclerosis: possible association with microvascular abnormalities and extent of fibrosis.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 53 (11). pp. 1799-1805. ISSN 1434-6621 (2015)

Szalay Balázs; Cseh Áron; Mészáros Gergő; Kovács László; Balog Attila; Vásárhelyi Barna: The impact of DMARD and anti-TNF therapy on functional characterization of short-term T-cell activation in patients with rheumatoid arthritis - A follow-up study.
PLOS ONE, 9 (8). Terjedelem: 7 p-Azonosító: e104298. ISSN 1932-6203 (2014)

Szalay Balázs; Vásárhelyi Barna; Cseh Áron; Tulassay Tivadar; Deák Magdolna; Kovács László; Balog Attila: The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.
CLINICAL RHEUMATOLOGY, 33 (2). pp. 175-185. ISSN 0770-3198 (2014)

Toldi Gergely; Szalay Balázs; Bekő Gabriella; Kovács László; Vásárhelyi Barna; Balog Attila: Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in ankylosing spondylitis.
JOINT BONE SPINE, 80 (1). pp. 96-98. ISSN 1297-319X (2013)

Szalay Balázs; Mészáros Gergő; Cseh Áron; Ács Lilla; Deák Magdolna; Kovács László; Vásárhelyi Barna; Balog Attila: Adaptive Immunity in Ankylosing Spondylitis: Phenotype and Functional Alterations of T-Cells before and during Infliximab Therapy.
CLINICAL AND DEVELOPMENTAL IMMUNOLOGY, 2012. Terjedelem : 8 p-Azonosító: 808724. ISSN 1740-2522 (2012)

Toldi Gergely; Szalay Balázs; Bekő Gabriella; Bocskai Márta; Deák Magdolna; Kovács László; Vásárhelyi Barna; Balog Attila: Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus.
BIOMARKERS, 17 (8). pp. 758-763. ISSN 1354-750X (2012)

Szalay Balázs; Ács Lilla; Vásárhelyi Barna; Kovács László; Balog Attila: Successful use of tocilizumab in a patient with rheumatoid arthritis following severe pancytopenia during etanercept therapy.
JCR: Journal of Clinical Rheumatology, 17 (7). pp. 377-379. ISSN 1076-1608 (2011)

A lista elkészítésének dátuma 2024. április 19. 08:41:17 CEST.